1.2K(top 1%)
papers
53.3K(top 0.1%)
citations
107(top 0.1%)
h-index
211(top 0.1%)
g-index
1.2K
all documents
62.8K
doc citations
4.5K
citing journals

Top Articles

#TitleJournalYearCitations
1Robust enumeration of cell subsets from tissue expression profilesNature Methods20158,460
2Determining cell type abundance and expression from bulk tissues with digital cytometryNature Biotechnology20192,396
3Profiling Tumor Infiltrating Immune Cells with CIBERSORTMethods in Molecular Biology20181,936
4An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageNature Medicine20141,771
5Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019943
6Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2020848
7Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryAnnals of Oncology2019842
8Integrated digital error suppression for improved detection of circulating tumor DNANature Biotechnology2016837
9Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesAmerican Journal of Human Genetics2019711
10Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingCancer Discovery2017701
11Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate CancerJAMA Oncology2020696
12Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019672
13Revised FIGO staging for carcinoma of the cervix uteriInternational Journal of Gynecology and Obstetrics2019612
14Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related FatigueJAMA Oncology2017580
15Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2022562
16Single-cell transcriptional diversity is a hallmark of developmental potentialScience2020557
17Detecting circular RNAs: bioinformatic and experimental challengesNature Reviews Genetics2016554
18Prostate Cancer, Version 1.2016Journal of the National Comprehensive Cancer Network: JNCCN2016544
19Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trialLancet Oncology, The2017447
20Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesNature Medicine2016437
21NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Journal of the National Comprehensive Cancer Network: JNCCN2017408
22Clinical lessons learned from the first leg of the CAR T cell journeyNature Medicine2019400
23Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019393
24Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapyLeukemia2019385
25Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019385
26Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2020383
27Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialLancet Oncology, The2019366
28Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome DatabaseGenetics in Medicine2020365
29Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementCell2018362
30Prevalence and Penetrance of Major Genes and Polygenes for Colorectal CancerCancer Epidemiology Biomarkers and Prevention2017341
31Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood CharacteristicsJournal of Clinical Oncology2018330
32Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemiaNature Biotechnology2019321
33NCCN Guidelines Insights: Breast Cancer, Version 1.2017Journal of the National Comprehensive Cancer Network: JNCCN2017317
34Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019314
35NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Journal of the National Comprehensive Cancer Network: JNCCN2020314
36Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentationProceedings of the National Academy of Sciences of the United States of America2015307
37Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trialJournal of Hematology and Oncology2017302
38Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN2019298
39EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesJournal of Clinical Oncology2019286
40NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020Journal of the National Comprehensive Cancer Network: JNCCN2020284
41Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019Journal of the National Comprehensive Cancer Network: JNCCN2019281
42NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017Journal of the National Comprehensive Cancer Network: JNCCN2017272
43Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencingBlood2015270
44Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analysesNature Genetics2020265
45Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk predictionNature Genetics2021264
46Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapyCancer2016254
47Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTxMethods in Molecular Biology2020249
48Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-IHaematologica2015246
49Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer SurvivorsClinical Breast Cancer2013237
50Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaJournal of Immunotherapy2019231